Bharat Biotech’s Covid-19 vaccine ‘Covaxin’ into phase-3 trials
Covid-19 vaccine - Covaxin - being developed by Bharat Biotech, is now undergoing phase-3 trials, Chairman and Managing Director of the company Krishna Ella said on Monday.
Speaking at a virtual programme organised by the Indian School of Business, Ella said the company is also working on another vaccine for Covid-19 which would be in the form of nasal drops and can be ready by next year.
“We partnered with ICMR (Indian Council of Medical Research) for a Covid-19 vaccine as we speak it will be entering the phase-3 trials,” he said.
Bharat Biotech is the only vaccine company in the world which has BSL3 production facility (Biosafety-level 3), he said.
Last month, the vaccine-maker said it had successfully completed interim analysis of Phase-I and -II trials of the vaccine and is initiating Phase-III trials in 26,000 participants.
Covaxin is being developed by BharatBiotech, in collaboration with the ICMR - National Institute of Virology (NIV).
The city-based vaccine-maker had, on October 2, sought the Drug Controller General of India’s (DCGI) permission to conduct phase-3 randomised double-blind placebo-controlled multicentre trial of its Covid-19 vaccine, sources said.
“We are working on another vaccine through nasal drops.
My feeling is by next year it will reach the population,” Ella said.
Bharat Biotech in September said it had entered into a licensing agreement with Washington University School of Medicine in St Louis for a novel ‘chimp-adenovirus’ (chimpanzee adenovirus), a single-dose intranasal vaccine for Covid-19.
Meanwhile a press release from Bharat Biotech said the Phase-III trials of Covaxin would involve 26,000 volunteers across 25 centres in India and it is being conducted in partnership with ICMR.
It is the largest clinical trial conducted for a Covid-19 vaccine in India.
This is Indias first phase-3 efficacy study for a Covid-19 vaccine, and the largest phase-III efficacy trial ever conducted in the country.
Participating volunteers, who undergo vaccination in the phase-II trials, would be monitored over the next year to detect occurrence of Covid-19.
The trial volunteers would receive two intramuscular injections approximately 28 days apart, it said.
Enter your email to get our daily newsletter in your inbox
- Shah directed that additional central paramilitary forces be deployed in Delhi with immediate effect and individuals and groups behind the Red Fort seize be brought to justice.
- While more than 100,000 people attended the parade during the previous years, with Covid-19 norms in place on Tuesday, the crowd was limited to 25,000.
- The Opposition, including the Congress, alleges that the government rushed the farm laws without proper discussion in Parliament. The Centre, however, says the reforms will lead to new opportunities in agriculture trade.
- The parliament canteen, now run by ITDC will offer as many as 58 items, both vegetarian and non-vegetarian, from January 27.
- Union minister for culture and tourism Prahlad Patel said government is addressing the lack of adventure sports equipment in Kargil.
- In contrast to the violence seen in the Capital, farmers held peaceful rallies across the country to protest against the farm laws.
- India put on display its war machines at a time when the country is locked in a tense border stand-off with China.
- The chaos and violence have raised questions about the future of the two-month-long agitation of farm unions.
- Bangladesh Prime Minister Sheikh Hasina, in a letter sent to her Indian counterpart, conveyed her greetings.
- Tuesday's decision to operate all trains comes a day after a meeting to resume local train services for all passengers was chaired by Maharashtra chief minister Uddhav Thackeray.
- Khattar said that unsavoury events on Tuesday deserved to be condemned in the strongest words.
- Governor RN Ravi said 'politics by gun' has stonewalled efforts to resolve the Naga political issue.